Evidence map›Paper›PMID 31049002›Full record

ArticleSaudi journal of biological sciences2019

Mitochondrial dysfunction mediated apoptosis of HT-29 cells through CS-PAC-AgNPs and investigation of genotoxic effects in zebra (

Mani Suganya, Balasubramanian Mythili Gnanamangai, Chandramohan Govindasamy, Mohamed Farouk Elsadek, Arivalagan Pugazhendhi, Veeramani Chinnadurai, Arokiyaraj Selvaraj, Balasubramani Ravindran, Soon Woong Chang, Ponnusamy Ponmurugan

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi journal of biological sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Silver Nanoparticles for the Therapy of Tuberculosis.International journal of nanomedicine · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Mani SuganyaDepartment of Biotechnology, K. S. Rangasamy College of Technology, Tiruchengode 637215, Tamil Nadu, India.
Balasubramanian Mythili GnanamangaiDepartment of Biotechnology, K. S. Rangasamy College of Technology, Tiruchengode 637215, Tamil Nadu, India.
Chandramohan GovindasamyDepartment of Community Health Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, Riyadh 11433, Saudi Arabia.
Mohamed Farouk ElsadekDepartment of Community Health Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, Riyadh 11433, Saudi Arabia.
Arivalagan PugazhendhiInnovative Green Product Synthesis and Renewable Environment Development Research Group, Faculty of Environment and Labour Safety, Ton Duc Thang University, Ho Chi Minh City, Viet Nam.
Veeramani ChinnaduraiDepartment of Community Health Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, Riyadh 11433, Saudi Arabia.
Arokiyaraj SelvarajDepartment of Food Science and Biotechnology, Sejong University, Seoul, Republic of Korea.
Balasubramani RavindranDepartment of Environmental Energy and Engineering, Kyonggi University, Youngtong -Gu, Suwon 16227, South Korea.
Soon Woong ChangDepartment of Environmental Energy and Engineering, Kyonggi University, Youngtong -Gu, Suwon 16227, South Korea.
Ponnusamy PonmuruganDepartment of Botany, Bharathiar University, Coimbatore 641 046, Tamil Nadu, India.
King Saud University · SAKyonggi University · KRBharathiar University · INSejong University · KRTon Duc Thang University · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study reports the validation of cancer nanotherapy using proanthocyanidin (PAC). Nowadays,

Indexed as

Characterizationin vivo (zebra fish) modelProanthocyanidinWestern blotting

Identifiers

PMID31049002
PMCPMC6486539
OpenAlexW2923435849

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.